GAUCHER-DISEASE
Drug
GENZYME CORPORATION
Total Payments
$1.4M
Transactions
1,480
Doctors
927
Companies
4
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $205,622 | 491 | 384 |
| 2018 | $140,647 | 551 | 399 |
| 2017 | $1.0M | 438 | 273 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.4M | 257 | 97.7% |
| Food and Beverage | $21,164 | 1,214 | 1.5% |
| Charitable Contribution | $11,400 | 9 | 0.8% |
Payments by Type
Research
$1.4M
257 transactions
General
$32,564
1,223 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| The Natural History of Type 1 Gaucher Disease, Impact of Modifier Genes and Enzyme Replacement Therapy | GENZYME CORPORATION | $761,771 | 0 |
| Gaucher LSD Data Registry | GENZYME CORPORATION | $92,562 | 0 |
| Gaucher Disease Registry | GENZYME CORPORATION | $91,984 | 0 |
| Q2 2017 Gaucher LSD Registry | GENZYME CORPORATION | $70,363 | 0 |
| Q3 2017 Gaucher LSD Registry | GENZYME CORPORATION | $64,911 | 0 |
| Q1 2017 Gaucher LSD Registry | GENZYME CORPORATION | $63,963 | 0 |
| Gaucher Registry | GENZYME CORPORATION | $62,500 | 0 |
| Q4 2016 Gaucher LSD Registry | GENZYME CORPORATION | $38,506 | 0 |
| Gaucher Registry | GENZYME CORPORATION | $33,793 | 0 |
| ICGG Gaucher Registry | GENZYME CORPORATION | $22,890 | 0 |
| Gaucher Disease Registry Protocol and Pregnancy Subregistry Protocol | GENZYME CORPORATION | $20,480 | 0 |
| Gaucher Disease Registry Protocol and Pregnancy Sub-Registry Protocol | SANOFI US SERVICES INC. | $7,480 | 0 |
| Q1 2016 Gaucher LSD Registry | GENZYME CORPORATION | $5,175 | 0 |
| Gaucher Registry Program | GENZYME CORPORATION | $4,080 | 0 |
| IRB Annual Review | GENZYME CORPORATION | $2,040 | 0 |
| Gaucher Disease Registry IRB fee for initial review & site start up fees | GENZYME CORPORATION | $2,015 | 0 |
| ICCG Gaucher Pregnancy Subregistry | GENZYME CORPORATION | $1,575 | 0 |
| Q1 2018 Gaucher LSD Registry | GENZYME CORPORATION | $1,555 | 0 |
| Pompe Registry | GENZYME CORPORATION | $1,325 | 0 |
| Q3 2016 Gaucher LSD Registry | GENZYME CORPORATION | $1,325 | 0 |
Top Doctors Receiving Payments for GAUCHER-DISEASE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Research Triangle Park, NC | $1.4M | 257 |
| , MD | Clinical Genetics (M.D.) | Washington, DC | $11,400 | 9 |
| , MD | Hematology & Oncology | Hot Springs, AR | $159.76 | 9 |
| , MD | Pediatric Hematology-Oncology | Gainesville, FL | $142.89 | 8 |
| , M.D | Internal Medicine | Miami, FL | $120.00 | 1 |
| , MD | Pediatric Hematology-Oncology | Dallas, TX | $109.72 | 2 |
| , M.D | Hematology & Oncology | Skokie, IL | $105.71 | 5 |
| , M.D | Internal Medicine | Newington, CT | $103.99 | 5 |
| , M.D | Hematology & Oncology | Hot Springs, AR | $101.23 | 6 |
| , MD | Pediatrics | Valhalla, NY | $99.74 | 1 |
| , M.D | Clinical Genetics (M.D.) | Morristown, NJ | $99.67 | 1 |
| , MD | Clinical Genetics (M.D.) | Boston, MA | $99.67 | 1 |
| , MD | Clinical Genetics (M.D.) | Tucson, AZ | $99.67 | 1 |
| , M.D.,PH.D | Clinical Genetics (M.D.) | Cleveland, OH | $99.67 | 1 |
| , M.D | Hematology & Oncology | Skokie, IL | $95.91 | 5 |
| , M.D | Hematology | Tampa, FL | $93.95 | 5 |
| , M.D | Hematology | Crystal River, FL | $92.35 | 6 |
| , MD | Pediatric Hematology-Oncology | Macon, GA | $88.75 | 5 |
| , M.D | Specialist | Manchester, CT | $88.29 | 5 |
| , M.D | Hematology & Oncology | Baltimore, MD | $87.52 | 6 |
| , M.D | Internal Medicine | Newington, CT | $85.09 | 4 |
| , M.D | Pediatrics | Sonoma, CA | $81.59 | 4 |
| , MD | Hematology & Oncology | Mayfield Hts, OH | $79.94 | 5 |
| , M.D | Hematology & Oncology | Little Rock, AR | $78.34 | 4 |
| , M.D | Hematology | Ocala, FL | $77.04 | 4 |
Ad
Manufacturing Companies
- GENZYME CORPORATION $1.4M
- SANOFI US SERVICES INC. $7,480
- Genzyme Corporation $780.07
- SANOFI-AVENTIS U.S. LLC $182.71
Product Information
- Type Drug
- Total Payments $1.4M
- Total Doctors 927
- Transactions 1,480
About GAUCHER-DISEASE
GAUCHER-DISEASE is a drug associated with $1.4M in payments to 927 healthcare providers, recorded across 1,480 transactions in the CMS Open Payments database. The primary manufacturer is GENZYME CORPORATION.
Payment data is available from 2017 to 2019. In 2019, $205,622 was paid across 491 transactions to 384 doctors.
The most common payment nature for GAUCHER-DISEASE is "Unspecified" ($1.4M, 97.7% of total).
GAUCHER-DISEASE is associated with 20 research studies, including "The Natural History of Type 1 Gaucher Disease, Impact of Modifier Genes and Enzyme Replacement Therapy" ($761,771).